What Is BPC-157 & TB-500?

 

BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment) are peptides often discussed together due to their potential roles in tissue repair and recovery. They are currently studied for their possible effects on healing, inflammation signaling, and regenerative processes.

​

These peptides are not hormones and are not approved weight-loss or metabolic medications. Interest in them primarily comes from musculoskeletal recovery and soft-tissue support.

 

How Do BPC-157 & TB-500 Work?

 

Although different in structure, both peptides are studied for their influence on repair pathways:

 

• BPC-157 — For effects on tendon, ligament, and gut-related repair signaling, as well as blood vessel formation pathways.

• TB-500 — A synthetic fragment related to thymosin beta-4, for its potential role in cell migration, tissue remodeling, and recovery processes.

• Inflammation signaling — Both are explored for possible roles in modulating inflammatory responses during healing.

• Cellular repair pathways — these peptides support communication between cells involved in regeneration.

 

Rather than targeting appetite or hormone receptors, these compounds are discussed in the context of tissue-support and recovery.

 

Potential Benefits?

​

• Tendon and ligament support

• Possible improvements in recovery and mobility

• Support for tissue repair signaling

• Anti-inflammatory effects observed in some laboratory studies

​

Side Effects and Safety Considerations?

​​

• Injection-site irritation or redness

• Headache or fatigue

• Temporary flushing or dizziness in some individuals

​​

​

Recommended Usage Information?

​

Estimated Half-Life:
• BPC-157 — Short-acting, believed to remain active for hours rather than days
• TB-500 — Longer-acting compared to BPC-157, with effects linked to tissue distribution rather than simple blood levels

​

Why it matters:
• They do not behave like long weekly metabolic drugs that build up to a classic steady state

​

Steady state concepts used for long-acting hormone therapies may not apply in the same way. Instead, consistency over time is typically emphasized in research discussions. We recommend starting on a dose of 1mg and increasing accordingly.

​

Gradual adjustments are generally preferred rather than rapid increases. More is not always better — maintaining a stable approach is when desired outcomes are achieved and may help reduce unwanted effects. 

​​

Our pens have an adjustable dosage of 1-4mg and have a shelf life of 12-18month.